A detailed history of Nemes Rush Group LLC transactions in Medtronic PLC stock. As of the latest transaction made, Nemes Rush Group LLC holds 9,359 shares of MDT stock, worth $826,025. This represents 0.1% of its overall portfolio holdings.

Number of Shares
9,359
Previous 13,139 28.77%
Holding current value
$826,025
Previous $1.15 Billion 35.67%
% of portfolio
0.1%
Previous 0.16%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

SELL
$78.71 - $87.02 $297,523 - $328,935
-3,780 Reduced 28.77%
9,359 $737 Million
Q1 2024

May 15, 2024

SELL
$82.84 - $88.09 $9.68 Million - $10.3 Million
-116,862 Reduced 89.89%
13,139 $1.15 Billion
Q4 2023

Feb 09, 2024

BUY
$69.43 - $83.43 $88,453 - $106,289
1,274 Added 0.99%
130,001 $10.7 Billion
Q3 2023

Nov 09, 2023

BUY
$78.22 - $90.4 $509,681 - $589,046
6,516 Added 5.33%
128,727 $10.1 Billion
Q2 2023

Aug 02, 2023

BUY
$79.47 - $91.38 $9.71 Million - $11.2 Million
122,211 New
122,211 $10.8 Billion

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $117B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Nemes Rush Group LLC Portfolio

Follow Nemes Rush Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nemes Rush Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nemes Rush Group LLC with notifications on news.